Association of lichen planus with metabolic syndrome – a case control study in a tertiary care centre

Cite this:
[1]
Nishant Saurabh Saxena, Nimisha Saxena, and Harsh Sharma, “Association of lichen planus with metabolic syndrome – a case control study in a tertiary care centre”, ijmhs, vol. 11, no. 03 (May - June), pp. 1695–1701, May 2021.
© 2022 Interactive Protocols
RIGHTS & PERMISSIONS
Article Views
256
Altmetric
1
Citations
-
LEARN ABOUT THESE METRICS
   PDF      HTML      E-PUB  

Abstract

Background: Lichen planus is an inflammatory papulosquamous disease
which affects skin and mucous membrane and cause metabolic
derangements.
Methods: This is an hospital based case control study during a span of 2
year (Jan2018-Dec 2019) which includes 60 cases of lichen planus and
60 age and sex matched controls. Relevant clinical history and physical
examination was done and collaborated with blood investigations.
Diagnosis was made based on IDF criteria.
Results: No significant association can be established between lichen
planus and metabolic syndrome ( p=0.278) Although prevalence of
hypertension was higher in cases as compared to controls (36% vs. 26%,
p=0.027) , TG levels (12% vs. 6%, p=0.030 and low HDLC levels (47%
vs. 33%, p=0.039). No significant association was established between
FBS and waist circumference with lichen planus.
Conclusions: Although no significant association can be established
between lichen planus and metabolic syndrome but its components such
as hypertension ,TG and HDLC were found to be associated with LP as
per the study .Therefore screening of these parameters in LP patients is
necessary to avoid future complications in these patients.
Keywords: Lichen planus, Metabolic syndrome, Hypertension, Triglyceride

KEYWORDS:

 Special Issue

Article Metrics Graph

Chart Graph | Range Graph

Content

Section

Source

License

All paper submissions must carry the following duly signed by all the authors:
“I certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published nor is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.”